Mucosal ImmunologyImmunologyPeer-reviewed journal article
Clostridioides difficile toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity
Jeffrey R. MaslankaiD, Jennifer LondreganiD, Joshua E. DennyiD, Ellie N Hulit, Nontokozo V. Mdluli, F. Christopher Peritore‐GalveiD, Md. Zahidul Alam, Mohamad‐Gabriel AlamehiD, Dana Borden LacyiD, Joseph P. ZackulariD, Michael C. AbtiD
Abstract
Clostridioides difficile colonizes the gastrointestinal tract and secretes two virulence factors: toxin A (TcdA) and toxin B (TcdB). Protective immunity against C. difficile infection is limited as patients are susceptible to multiple rounds of recurrent infections. The factors determining whether immunity to TcdA and TcdB is generated remain incompletely defined. We determined that C. difficile-infected mice generate antibody and IL-17A-producing CD4+ T cell responses to TcdA, but not TcdB. To determine the mechanism of the failed anti-TcdB immunity, C. difficile mutant strains expressing glucosyltransferase inactive (GTX) TcdA, and/or glucosyltransferase inactive TcdB were used. Infection with TcdBGTX or dual mutant (TcdAGTX TcdBGTX) restored TcdB-specific antibody responses, while infection with TcdAGTX or TcdAGTX TcdBGTX led to an earlier induction of TcdA-specific antibodies. Finally, infection with the dual GTX mutant enhanced TcdA and TcdB-specific CD4+ T cell responses. These data demonstrate that the glucosyltransferase activity of TcdA and TcdB hinders the antigen-specific adaptive immune response to itself and may be a mechanism that underlies high recurrence rates following C. difficile infection in patients.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 5
- FWCI
- 3.85
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection
F. C. Peritore-Galve, J. A. Shupe, … D. B. Lacy·PLOS PathogensPeer-reviewed·Feb 17, 2022
- Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B-specific CD4+ T cell responses
Jeffrey R. Maslanka, Qianxuan She, … Michael C. Abt·The Journal of ImmunologyPeer-reviewed·Aug 1, 2026
- Isofagomine inhibits multiple TcdB variants and protects mice from Clostridioides difficile induced mortality
A. S. Paparella, I. Brew, … V. L. Schramm·bioRxiv·Sep 19, 2023
- IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity
Farha Naz, Md Jashim Uddin, … William A. Petri·Journal of Clinical InvestigationPeer-reviewed·Mar 6, 2025
- Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.
Farha Naz, Nicholas Hagspiel, … Mayuresh M. Abhyankar·npj VaccinesPeer-reviewed·Feb 18, 2025
- Receptor-binding domain 2 of Clostridioides difficile binary toxin as a promising vaccine component against C. difficile infection
Shaohui Wang, Joshua Heuler, … Xingmin Sun·bioRxiv·Aug 31, 2026